|
Volumn 185, Issue 4, 2005, Pages 1082-
|
Imaging bone metastases in breast cancer [9]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALKALINE PHOSPHATASE;
FLUORODEOXYGLUCOSE F 18;
GLUCOSE DERIVATIVE;
PROSTATE SPECIFIC ANTIGEN;
DIAGNOSTIC AGENT;
RADIOPHARMACEUTICAL AGENT;
BONE DESTRUCTION;
BONE DEVELOPMENT;
BONE METASTASIS;
BONE SCINTISCANNING;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CARCINOID;
HUMAN;
LETTER;
OSTEOBLAST;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATE TUMOR;
TREATMENT PLANNING;
TUMOR CELL;
VASCULARIZATION;
BONE TUMOR;
BREAST TUMOR;
FEMALE;
METASTASIS;
NOTE;
PATHOLOGY;
SCINTISCANNING;
SENSITIVITY AND SPECIFICITY;
SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;
BONE NEOPLASMS;
BREAST NEOPLASMS;
FEMALE;
FLUORODEOXYGLUCOSE F18;
HUMANS;
POSITRON-EMISSION TOMOGRAPHY;
RADIOPHARMACEUTICALS;
SENSITIVITY AND SPECIFICITY;
TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;
|
EID: 32944479757
PISSN: 0361803X
EISSN: None
Source Type: Journal
DOI: 10.2214/AJR.05.5143 Document Type: Letter |
Times cited : (2)
|
References (3)
|